This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 21/9/2203    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Choudhary, S. Articles by Brasier, A. R. Search for Related Content PubMed PubMed Citation Articles by Choudhary, S. Articles by Brasier, A. R. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH

Involvement of a Novel Rac/RhoA Guanosine Triphosphatase-Nuclear Factor-B Inducing Kinase Signaling Pathway Mediating Angiotensin II-Induced RelA Transactivation

Departments of Biochemistry and Molecular Biology (S.C.) and Internal Medicine (M.L., R.C.) and the Sealy Center for Molecular Medicine (A.R.B.), University of Texas Medical Branch, Galveston, Texas 77555-1060

Address all correspondence and requests for reprints to: Allan R. Brasier, M.D., Division of Endocrinology, MRB 8.138, University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555-1060. E-mail: arbrasie{at}utmb.edu.

Angiotensin II (Ang II) is the major effector peptide of the renin angiotensin system that induces inflammatory gene expression through the nuclear factor-B (NF-B) transcription factor. Activation of latent cytoplasmic NF-B is controlled by distinct pathways, the best known being the canonical pathway controlling IB kinase activation. Interestingly, Ang II only weakly activates the canonical pathway. Although basal nucleocytoplasmic RelA shuttling is required for Ang II stimulation, changes in RelA translocation do not account for its transcriptional effect. Instead, Ang II rapidly induced RelA phosphorylation at Ser residue 536, and complex formation with the Ser⁵³⁶ kinase known as the NF-B-inducing kinase (NIK)/MEKK14. The requirement of NIK in Ang II-inducible transcription was shown by expressing a dominant-negative NIK or small interfering RNA (siRNA)-mediated knockdown; both inhibited Ang II-induced transcription. Conversely, constitutively active NIK potently induced RelA transactivation activity. Consistent with its actions independent of the canonical pathway, NIK induces the activity of the RelA transactivation domains -1 and -2 in constitutively nuclear GAL4-RelA fusion proteins that do not bind IB. Ang II induces NIK activity, phosphorylation of its endogenous IB kinase substrate, and induction of nuclear NF-B2 (p52) processing. NIK down-regulation prevents Ang II-induced phospho-Ser⁵³⁶ RelA formation, indicating that it is essential for RelA activation. The Ang II pathway further involves the RhoA small GTP-binding protein because RhoA inhibition blocks Ang II-induced transcriptional activity and formation of phospho-Ser⁵³⁶ RelA formation. Finally, we demonstrate that Ang II infusion in vivo rapidly induces phospho-Ser⁵³⁶ RelA formation and activation of the NF-B-dependent IL-6 gene. These data indicate that Ang II induces NF-B-dependent transcription through an alternative pathway, being largely independent of IB proteolysis, but mediated by the small GTPases Rac/RhoA, required for NIK·RelA complex formation and inducible Ser⁵³⁶ RelA phosphorylation.